Q32 Bio Inc. — Director's Dealing 2018

Mar 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2018-03-27

Reporting Person: PARMAR KUSH (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-27	Employee stock option	$16.00	A	31160	Acquired	2028-03-27	Common Stock (31160)	Direct

Footnotes

F1: The option will vest in three equal annual installments beginning on March 27, 2019.